MedTrace Logo

AcoArt IV / SFA in China:Drug-eluting Balloon for SFA Angioplasty Evaluation in China

NCT03267056 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2020-08-19

No results posted yet for this study

Summary

The registry is a prospective, multicenter, single arm post-market real-world registry in China assessing the clinical use, safety and outcomes of the Orchid 035 DCB Catheter in the Superficial Femoral Artery (SFA) and Popliteal Arteries (PA).

Conditions

Interventions

DEVICE

drug eluting balloon catheter (trade name: Orchid)

use drug eluting balloon catheter(trade name: Orchid) to inflate the stenosis or occlusion in superficial femoral artery(SFA) and/or popliteal artery

Sponsors & Collaborators

  • Acotec Scientific Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Wei Guo · Chinese PLA General Hospital

  • Yinghua Zou · Peking University First Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-19
Primary Completion
2020-04-30
Completion
2020-06-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03267056 on ClinicalTrials.gov